ObsEva SA (Nasdaq:OBSV), a biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that impact a woman’s reproductive health and pregnancy, visits the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
ObsEva SA (Nasdaq:OBSV), a biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that impact a woman’s reproductive health and pregnancy, visits the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).